Sign in

Michael Levin

@mglevin.bsky.social
351 followers 188 following 4 posts

🫀Cardiologist @PennCardiology and @VAPhiladelphia 🧬Interested in human genetics of cardiovascular disease | #rstats enthusiast | mglev1n.github.io

PostsRepliesMedia
Reposted by Michael Levin
Neil Davies @neilmdavies.bsky.social · 20/04/2026
We have a new paper outlining the latest challenges and future directions for Mendelian randomization. We used AI to review 10,126 abstracts from studies using Mendelian randomization. www.nature.com/articles/s41...
nature.com
Challenges and future directions for Mendelian randomization - Nature Genetics
Mendelian randomization is widely used but relies on specific assumptions that are rarely systematically assessed. This Perspective argues that researchers should rigorously test these assumptions thr...
173
Reposted by Michael Levin
JAMA Cardiology @jamacardiology.com · 30/01/2026
JAMA Cardiology marks its 10th anniversary with gratitude to founding Editor in Chief Robert O. Bonow, MD, MS. In his farewell Editorial, Bonow reflects on building a top-cited cardiovascular journal: “It’s a very rare, once‑in‑a‑lifetime opportunity.” ja.ma/3NM60Ow
Cover of JAMA Cardiology features Robert O. Bonow, MD, MS, along with the text 'The First Decade of JAMA Cardiology'. Published online January 30, 2026.
063
Reposted by Michael Levin
lwilsbacher.bsky.social @lwilsbacher.bsky.social · 24/10/2025
New event at #AHA2025! GPM Symposium Model Systems: Preclinical to Phase I Bridge Nov 7 12:30-5:15 Learn state-of-the-art systems to bridge therapies from the Preclinical to Phase I trials Speakers: Kricket Seidman, Joe Wu, Kiran Musunuru, Vicki Parikh, Eric Adler, and more!
153
Reposted by Michael Levin
Marios Georgakis @mariosgeorgakis.bsky.social · 19/08/2025
Amid the hype of using polygenic scores for embryo selection, some thoughts on their implementation potential in real-world settings (and problems) 👇
121
Reposted by Michael Levin
Marios Georgakis @mariosgeorgakis.bsky.social · 24/04/2025
Massive multi-ancestry GWAS resource for 1,167 clinical traits & diseases in 6 global biobanks (n=1,789,365) 👉29,139 locus-trait pairs 👉2,624 non-overlapping loci across the genome 👉associated with 6 traits each (median) 👉colocalization across traits for 72% of loci [1/3]
1167
Reposted by Michael Levin
Pradeep Natarajan @pnatarajanmd.bsky.social · 23/04/2025
Very excited to share our preprint led by M. Levin @skoyama.bsky.social J. Woerner & with S. Damrauer assessing genome-wide pleiotropy of >1,000 clinical traits across ~1.7M individuals with nearly 30K locus-trait associations! www.medrxiv.org/content/10.1... @medrxivpreprint.bsky.social
34427
Reposted by Michael Levin
The Polygenic Score Catalog @pgscatalog.bsky.social · 17/04/2025
Thanks to @mglevin.bsky.social for sharing this new heart failure PRS from @naturegenet.bsky.social, 🔗: www.pgscatalog.org/score/PGS005.... This and more in the latest release, submit your scores at www.pgscatalog.org/submit!
pgscatalog.org
PGS Catalog - PGS005097 / Heart failure (Polygenic Score)
The Polygenic Score (PGS) Catalog is an open database of published PGS and the relevant metadata needed to apply and evaluate them correctly.
1103
Reposted by Michael Levin
UPENN_ITMAT @itmat.bsky.social · 11/04/2025
105 new loci at #genome-wide significance linked to 5 distinct traits/diseases with shared #GeneticSusceptibility to #HeartFailure doi.org/10.1038/s415... @DavidSMLee @bvoight28.bsky.social @MarylynRitchie @damrauer #TranslationalScience
doi.org
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum - Nature Genetics
Common-variant and rare-variant association analyses combining datasets from multiple populations yield insights into the genetic architecture of all-cause heart failure across the allele-frequency sp...
022
Reposted by Michael Levin
medRxivpreprint @medrxivpreprint.bsky.social · 08/04/2025
Angiographic Burden of Coronary Atherosclerosis Contributes To Adverse ASCVD Outcomes Independent Of Traditional Risk Factors www.medrxiv.org/content/10.1101/202…
021
Michael Levin @mglevin.bsky.social · 08/04/2025
Excited to see this published: rdcu.be/egHer Common- and rare-variant genetic analyses of heart failure in >2 million individuals 🔘 Dozens of new common variant loci 🔘 Confirmation of rare damaging variation in "definitive" cardiomyopathy genes 🔘 A PRS modifies penetrance of TTNtv
rdcu.be
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
Nature Genetics - Common-variant and rare-variant association analyses combining datasets from multiple populations yield insights into the genetic architecture of all-cause heart failure across...
1153
Reposted by Michael Levin
Sam Lambert @iamslambert.bsky.social · 01/04/2025
Interested in calculating polygenic scores in the All Of Us workbench? Like those from @pgscatalog.bsky.social? Take a look at our new documentation for how to run pgsc_calc in the cloud environment: pgsc-calc.readthedocs.io/en/latest/ho.... Very much work-in-progress, optimisations incoming!
pgsc-calc.readthedocs.io
Running the PGS Catalog Calculator via the All of Us workbench — Polygenic Score (PGS) Catalog Calculator documentation
12410
Reposted by Michael Levin
Mike Inouye @mikeinouye.bsky.social · 31/03/2025
Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events www.ahajournals.org/doi/10.1161/...
0133
Reposted by Michael Levin
Waggoner Lab @labwaggoner.bsky.social · 05/03/2025
CXCL12 drives natural variation in coronary artery anatomy across diverse populations @cellcellpress.bsky.social @tassimes.bsky.social www.cell.com/cell/fulltex...
063
Reposted by Michael Levin
Jodie Ingles @jodieingles27.bsky.social · 18/02/2025
Q: How many genes should be tested for patients with hypertrophic cardiomyopathy? A: 29 Excited to share our latest: Re-Appraisal of HCM genes by our ClinGen Hereditary CVD Gene Curation Expert Panel out today in @jaccjournals.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition affecting ∼1 in 500 and exhibits marked genetic heterogeneity. Previously publishe…
25428
Reposted by Michael Levin
JAMA @jama.com · 11/01/2025
Despite similar performance at the population level, different coronary heart disease polygenic risk scores produced highly variable individual-level risk estimates. ja.ma/3W8RykL
Figure 2.  Concordance of Individual Scores in the Primary All of Us (AOU) Research Sample
0133
Reposted by Michael Levin
JAMA @jama.com · 16/11/2024
🚀 Here are key takeaways from today's JAMA and JAMA Cardiology presentations at #AHA24: Despite similar performance at the population level, different coronary heart disease polygenic risk scores produced highly variable individual-level risk estimates. ➡️ ja.ma/4fKewpK
Figure showing concordance of individual scores in the Primary All of Us (AOU) research sample.
1207
Michael Levin @mglevin.bsky.social · 16/11/2024
🚨 Our work exploring polygenic risk scores for Coronary Heart Disease is now out in @JAMA_current and presented at #AHA24 by all-star #SarnoffCardio fellow Sarah Abramowitz!
0106
Michael Levin @mglevin.bsky.social · 15/11/2024
Excited for these trainee presentations from the lab at @ahascience.bsky.social #AHA24, spanning cardiovascular genomics and precision medicine. Come check out these talks, moderated posters, and posters to learn more about our work!
173